Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection.

@article{Vigan1999ClinicalAI,
  title={Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection.},
  author={Alessandra M Vigan{\`o} and Leonard G Dally and Dorella Bricalli and N{\'u}ria Sala and Maria Franca Pirillo and Marina Saresella and Daria Lucia Trabattoni and Stefano Vella and Mario Clerici and Nicola Principi},
  journal={The Journal of pediatrics},
  year={1999},
  volume={135 6},
  pages={675-82}
}
Clinical, virologic, and immunologic outcomes were analyzed in children with vertically transmitted human immunodeficiency virus (HIV) infection (n = 25) and clinical symptoms and evidence of immunosuppression to establish the efficacy of 18 months' treatment with stavudine, lamivudine, and indinavir. Children were naive for treatment with protease inhibitors and lamivudine and had minimal exposure to stavudine. At 1, 6, 12, and 18 months, the proportions of patients with HIV-RNA <400 copies/mL… CONTINUE READING